These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 15612143)

  • 1. Systemic adverse effects of hepatitis B vaccines are rare.
    Prescrire Int; 2004 Dec; 13(74):218-23. PubMed ID: 15612143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B vaccine and risk of multiple sclerosis.
    DeStefano F; Verstraeten T; Chen RT
    Expert Rev Vaccines; 2002 Dec; 1(4):461-6. PubMed ID: 12901584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune diseases and vaccinations.
    Vial T; Descotes J
    Eur J Dermatol; 2004; 14(2):86-90. PubMed ID: 15196997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B vaccine and risk of relapse after a first childhood episode of CNS inflammatory demyelination.
    Mikaeloff Y; Caridade G; Assi S; Tardieu M; Suissa S;
    Brain; 2007 Apr; 130(Pt 4):1105-10. PubMed ID: 17276994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B vaccination and multiple sclerosis: evidence from a systematic review.
    Demicheli V; Rivetti A; Di Pietrantonj C; Clements CJ; Jefferson T
    J Viral Hepat; 2003 Sep; 10(5):343-4. PubMed ID: 12969184
    [No Abstract]   [Full Text] [Related]  

  • 6. Vaccinations and risk of central nervous system demyelinating diseases in adults.
    DeStefano F; Verstraeten T; Jackson LA; Okoro CA; Benson P; Black SB; Shinefield HR; Mullooly JP; Likosky W; Chen RT;
    Arch Neurol; 2003 Apr; 60(4):504-9. PubMed ID: 12707063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination and autoimmunity-'vaccinosis': a dangerous liaison?
    Shoenfeld Y; Aron-Maor A
    J Autoimmun; 2000 Feb; 14(1):1-10. PubMed ID: 10648110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Don't exaggerate the systemic adverse effects of hepatitis B vaccination: the vaccine benefits people at risk.
    Prescrire Int; 2000 Apr; 9(46):59-63. PubMed ID: 11503792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A one year followup of chronic arthritis following rubella and hepatitis B vaccination based upon analysis of the Vaccine Adverse Events Reporting System (VAERS) database.
    Geier DA; Geier MR
    Clin Exp Rheumatol; 2002; 20(6):767-71. PubMed ID: 12508767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination and autoimmune diseases: the argument against.
    Rubinstein E
    Isr Med Assoc J; 2004 Jul; 6(7):433-5. PubMed ID: 15274538
    [No Abstract]   [Full Text] [Related]  

  • 11. [Central nervous system demyelinating events and hepatitis B vaccine: a new episode of the never ending French saga!].
    Costagliola D
    Rev Epidemiol Sante Publique; 2008 Dec; 56(6):379-81. PubMed ID: 19019601
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis B vaccine and central nervous system demyelinating diseases. Viral Hepatitis Prevention Board.
    Halsey NA; Duclos P; Van Damme P; Margolis H
    Pediatr Infect Dis J; 1999 Jan; 18(1):23-4. PubMed ID: 9951975
    [No Abstract]   [Full Text] [Related]  

  • 13. Multiple sclerosis and vaccination against hepatitis B: analysis of risk benefit profile.
    Tosti ME; Traversa G; Bianco E; Mele A
    Ital J Gastroenterol Hepatol; 1999; 31(5):388-91. PubMed ID: 10470598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A shadow falls on hepatitis B vaccination effort.
    Marshall E
    Science; 1998 Jul; 281(5377):630-1. PubMed ID: 9714670
    [No Abstract]   [Full Text] [Related]  

  • 15. Autoimmune diseases after hepatitis B immunization in adults: Literature review and meta-analysis, with reference to 'autoimmune/autoinflammatory syndrome induced by adjuvants' (ASIA).
    Elwood JM; Ameratunga R
    Vaccine; 2018 Sep; 36(38):5796-5802. PubMed ID: 30100071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatitis B vaccination: a review].
    Launay O; Floret D
    Med Sci (Paris); 2015 May; 31(5):551-8. PubMed ID: 26059307
    [No Abstract]   [Full Text] [Related]  

  • 17. Multiple sclerosis and hepatitis B vaccine?
    Hall A; Kane M; Roure C; Meheus A
    Vaccine; 1999 Jun; 17(20-21):2473-5. PubMed ID: 10418891
    [No Abstract]   [Full Text] [Related]  

  • 18. Guillain-Barré syndrome after vaccination in United States: data from the Centers for Disease Control and Prevention/Food and Drug Administration Vaccine Adverse Event Reporting System (1990-2005).
    Souayah N; Nasar A; Suri MF; Qureshi AI
    J Clin Neuromuscul Dis; 2009 Sep; 11(1):1-6. PubMed ID: 19730016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Central nervous system demyelinating disease following hepatitis B vaccination with GenHevac B. Review of ten years of spontaneous notifications (1989-1998)].
    Soubeyrand B; Boisnard F; Bruel M; Debois H; Delattre D; Gauthier A; Soum S; Thébault C
    Presse Med; 2000 Apr; 29(14):775-80. PubMed ID: 10816715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.
    Zangwill KM; Eriksen E; Lee M; Lee J; Marcy SM; Friedland LR; Weston W; Howe B; Ward JI
    Pediatrics; 2008 Dec; 122(6):e1179-85. PubMed ID: 19047220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.